NASDAQ$SCLX
Scilex Holding Company "Restricted Stock" · Q1 2025 earnings
Q1 2025 earnings · · After market close · Investor relations
Briefing
Scilex Holding reported Q1 2025 revenue of $5.0M, a net loss of $26.1M, diluted EPS of $-2.26.
For Q1 2025, Scilex Holding reported Revenue was $5.0M, net loss was $26.1M, diluted EPS was $-2.26. The quarterly filing discusses operating priorities, liquidity, and sector-specific risks in MD&A.
- Revenue $5.0M for Q1 2025.
- Net loss $26.1M.
- Diluted EPS $-2.26.
Headline financials
Revenue & EPS history
Scilex · Revenue · Quarterly
$5M
Forward guidance
Outlook emphasizes clinical milestones, cash runway, and operating expense discipline.
Tailwinds
- Pipeline progress and partnership optionality.
- Cost controls and balance-sheet flexibility.
Headwinds
- Operating losses until commercialization.
- Trial timing and regulatory uncertainty.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports · overlaid with Q1 2025
-2.8%
Avg return
Earnings day
-0.6%
Avg return
5 days after
+3.9%
Avg return
30 days after
32%
7 / 22 earnings
Positive
+24.5%
Q1 2023
Best reaction
-17.9%
Q2 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +0.8% | +1.0% | +24.7% | |
| Q4 2025 | -1.0% | +16.1% | +34.8% | |
| Q4 2024 | -11.6% | -12.4% | -22.8% | |
| Q3 2025 | -11.2% | +7.1% | -6.6% | |
| Q2 2025 | -17.9% | -14.5% | +25.1% | |
| Q1 2025 | +9.1% | +1.2% | +24.7% | |
| Q3 2024 | -9.8% | -6.2% | -24.5% | |
| Q2 2024 | -5.3% | -6.8% | -19.7% | |
| Q1 2024 | +7.3% | +20.8% | +93.3% | |
| Q4 2023 | -5.0% | -2.1% | -7.1% | |
| Q3 2023 | -1.6% | -16.4% | +0.0% | |
| Q2 2023 | -15.5% | -8.1% | -41.1% | |
| Q1 2023 | +24.5% | +30.1% | +23.0% | |
| Q4 2022 | -12.3% | -20.8% | +40.5% | |
| Q3 2022 | -12.1% | -4.1% | -60.0% | |
| Q2 2022 | +0.0% | +0.0% | +0.2% | |
| Q1 2022 | -0.3% | -0.1% | +0.0% | |
| Q4 2021 | +0.1% | +0.2% | +0.5% | |
| Q3 2021 | +0.0% | +0.2% | +0.0% | |
| Q2 2021 | +0.0% | -0.1% | +0.1% | |
| Q1 2021 | +0.2% | +0.3% | +0.7% | |
| Q4 2020 | +0.2% | +0.3% | +0.7% | |
| Q3 2020 | — | — | — | |
| Q2 2020 | — | — | — | |
| Q1 2020 | — | — | — | |
| Q4 2019 | — | — | — | |
| Q3 2019 | — | — | — | |
| Q2 2019 | — | — | — | |
| Q1 2019 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro